 Christian Francom
Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngoscopy | 2 | 2020 | 109 | 1.160 |
Why?
| | Bronchoscopy | 2 | 2020 | 223 | 1.150 |
Why?
| | Micrognathism | 2 | 2025 | 18 | 1.150 |
Why?
| | Airway Obstruction | 2 | 2025 | 162 | 0.970 |
Why?
| | Pierre Robin Syndrome | 1 | 2025 | 9 | 0.940 |
Why?
| | Osteogenesis, Distraction | 1 | 2025 | 18 | 0.920 |
Why?
| | Nasal Septal Perforation | 1 | 2024 | 4 | 0.900 |
Why?
| | Mandible | 1 | 2025 | 78 | 0.900 |
Why?
| | Fascia | 1 | 2024 | 17 | 0.890 |
Why?
| | Eustachian Tube | 1 | 2024 | 8 | 0.880 |
Why?
| | Middle Ear Ventilation | 1 | 2024 | 15 | 0.880 |
Why?
| | Cleft Lip | 1 | 2024 | 52 | 0.840 |
Why?
| | Cleft Palate | 1 | 2024 | 68 | 0.820 |
Why?
| | Postoperative Care | 1 | 2025 | 261 | 0.820 |
Why?
| | Enteral Nutrition | 1 | 2025 | 202 | 0.800 |
Why?
| | Liposarcoma, Myxoid | 1 | 2019 | 10 | 0.630 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2019 | 14 | 0.620 |
Why?
| | Facial Neoplasms | 1 | 2019 | 19 | 0.620 |
Why?
| | Respiratory System | 2 | 2019 | 157 | 0.570 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.530 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 257 | 0.500 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.460 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.460 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.360 |
Why?
| | Mouth Neoplasms | 2 | 2025 | 120 | 0.310 |
Why?
| | Child | 14 | 2025 | 21935 | 0.290 |
Why?
| | Child, Preschool | 6 | 2025 | 11074 | 0.270 |
Why?
| | Palatine Tonsil | 2 | 2024 | 48 | 0.270 |
Why?
| | Infant | 4 | 2025 | 9465 | 0.240 |
Why?
| | Papilloma | 1 | 2025 | 52 | 0.240 |
Why?
| | Retrospective Studies | 9 | 2025 | 15657 | 0.230 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2025 | 63 | 0.230 |
Why?
| | Temporal Muscle | 1 | 2024 | 3 | 0.230 |
Why?
| | Branchial Region | 1 | 2024 | 36 | 0.220 |
Why?
| | Absorbable Implants | 1 | 2024 | 35 | 0.220 |
Why?
| | Hearing Loss, Conductive | 1 | 2024 | 25 | 0.220 |
Why?
| | Polyesters | 1 | 2024 | 76 | 0.210 |
Why?
| | Male | 13 | 2025 | 67762 | 0.210 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 5 | 0.210 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 6 | 0.210 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 166 | 0.210 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 14 | 0.210 |
Why?
| | Cholesteatoma | 1 | 2023 | 10 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 98 | 0.200 |
Why?
| | Croup | 1 | 2023 | 19 | 0.200 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 752 | 0.200 |
Why?
| | Delphi Technique | 1 | 2024 | 280 | 0.200 |
Why?
| | Ultrasonography, Prenatal | 1 | 2024 | 285 | 0.190 |
Why?
| | Tympanoplasty | 1 | 2022 | 8 | 0.190 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 17 | 0.190 |
Why?
| | Female | 13 | 2025 | 73304 | 0.180 |
Why?
| | Humans | 20 | 2025 | 137585 | 0.180 |
Why?
| | Otitis Media | 1 | 2024 | 165 | 0.180 |
Why?
| | Treatment Outcome | 3 | 2025 | 10811 | 0.180 |
Why?
| | Papillomavirus Infections | 1 | 2025 | 325 | 0.180 |
Why?
| | Laryngeal Diseases | 1 | 2021 | 31 | 0.170 |
Why?
| | Perioperative Period | 1 | 2020 | 56 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 293 | 0.160 |
Why?
| | Abscess | 1 | 2020 | 75 | 0.160 |
Why?
| | Tonsillectomy | 1 | 2021 | 89 | 0.160 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3566 | 0.160 |
Why?
| | Ancillary Services, Hospital | 1 | 2019 | 2 | 0.160 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 156 | 0.160 |
Why?
| | Prospective Studies | 2 | 2024 | 7604 | 0.160 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 343 | 0.150 |
Why?
| | Tracheostomy | 1 | 2021 | 133 | 0.150 |
Why?
| | Adolescent | 6 | 2025 | 21513 | 0.150 |
Why?
| | Clinical Protocols | 1 | 2020 | 271 | 0.150 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 170 | 0.150 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 184 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 209 | 0.130 |
Why?
| | Prevalence | 1 | 2024 | 2734 | 0.130 |
Why?
| | Trachea | 1 | 2016 | 237 | 0.110 |
Why?
| | Time Factors | 1 | 2025 | 6828 | 0.110 |
Why?
| | Patient Care Team | 1 | 2019 | 631 | 0.110 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 75 | 0.100 |
Why?
| | Receptor, IGF Type 1 | 1 | 2012 | 65 | 0.100 |
Why?
| | Quinazolines | 1 | 2012 | 251 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 2024 | 201 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3284 | 0.080 |
Why?
| | Asthma | 1 | 2023 | 2295 | 0.080 |
Why?
| | ErbB Receptors | 1 | 2012 | 614 | 0.080 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 683 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 916 | 0.060 |
Why?
| | Anatomic Landmarks | 1 | 2024 | 29 | 0.060 |
Why?
| | Jaw | 1 | 2024 | 26 | 0.060 |
Why?
| | Papillomaviridae | 1 | 2025 | 125 | 0.060 |
Why?
| | Craniofacial Abnormalities | 1 | 2024 | 72 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 83 | 0.050 |
Why?
| | Ear Canal | 1 | 2023 | 15 | 0.050 |
Why?
| | Ear | 1 | 2023 | 34 | 0.050 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2023 | 42 | 0.050 |
Why?
| | Otolaryngology | 1 | 2024 | 96 | 0.050 |
Why?
| | Hyperplasia | 1 | 2023 | 175 | 0.050 |
Why?
| | Congenital Abnormalities | 1 | 2023 | 92 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 245 | 0.050 |
Why?
| | Cough | 1 | 2023 | 122 | 0.050 |
Why?
| | Down-Regulation | 1 | 2024 | 657 | 0.050 |
Why?
| | Consensus | 1 | 2024 | 683 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2021 | 72 | 0.040 |
Why?
| | Obstetric Labor Complications | 1 | 2021 | 34 | 0.040 |
Why?
| | Nasal Septum | 1 | 2020 | 25 | 0.040 |
Why?
| | Hematoma | 1 | 2020 | 53 | 0.040 |
Why?
| | Pregnancy | 2 | 2024 | 6763 | 0.040 |
Why?
| | Cesarean Section | 1 | 2021 | 184 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 452 | 0.040 |
Why?
| | Swine | 1 | 2022 | 775 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 565 | 0.040 |
Why?
| | Models, Organizational | 1 | 2019 | 151 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 140 | 0.040 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 191 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 910 | 0.030 |
Why?
| | Program Development | 1 | 2019 | 364 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 591 | 0.030 |
Why?
| | Fluoroscopy | 1 | 2016 | 154 | 0.030 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.030 |
Why?
| | Endoscopy | 1 | 2016 | 318 | 0.030 |
Why?
| | Sheep | 1 | 2016 | 856 | 0.030 |
Why?
| | Biomarkers | 1 | 2024 | 4149 | 0.030 |
Why?
| | Cyclin D | 1 | 2012 | 9 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2012 | 24 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2012 | 82 | 0.020 |
Why?
| | S Phase | 1 | 2012 | 77 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 580 | 0.020 |
Why?
| | Cytoplasm | 1 | 2012 | 274 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2012 | 319 | 0.020 |
Why?
| | Cell Cycle | 1 | 2012 | 601 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2012 | 620 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6079 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1783 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 470 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2012 | 706 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2057 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1759 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 801 | 0.020 |
Why?
| | Animals | 2 | 2022 | 36940 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 13209 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3412 | 0.010 |
Why?
|
|
Francom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|